Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleArticles on Covid-19

Raloxifene and Bazedoxifene Could Be Promising Candidates for Preventing the COVID-19 Related Cytokine Storm, ARDS and Mortality

KAREL SMETANA, DANIEL ROSEL and JAN BRÁBEK
In Vivo September 2020, 34 (5) 3027-3028; DOI: https://doi.org/10.21873/invivo.12135
KAREL SMETANA JR.
1Institute of Anatomy, First Faculty of Medicine, Charles University, Prague, Czech Republic
2BIOCEV, Vestec, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jan.brabek{at}natur.cuni.cz karel.smetana{at}lf1.cuni.cz
DANIEL ROSEL
2BIOCEV, Vestec, Czech Republic
3Department of Cell Biology, Faculty of Sciences, Charles University, Prague, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JAN BRÁBEK
2BIOCEV, Vestec, Czech Republic
3Department of Cell Biology, Faculty of Sciences, Charles University, Prague, Czech Republic
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jan.brabek{at}natur.cuni.cz karel.smetana{at}lf1.cuni.cz
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 34 no. 5 3027-3028
DOI 
https://doi.org/10.21873/invivo.12135
PMID 
32871847

Published By 
International Institute of Anticancer Research
Print ISSN 
0258-851X
Online ISSN 
1791-7549
History 
  • Received June 27, 2020
  • Revision received June 29, 2020
  • Accepted July 1, 2020
  • Published online August 31, 2020.

Copyright & License 
Copyright © 2020 The Author(s). Published by the International Institute of Anticancer Research.

Author Information

  1. KAREL SMETANA JR.1,2⇑,
  2. DANIEL ROSEL2,3 and
  3. JAN BRÁBEK2,3⇑
  1. 1Institute of Anatomy, First Faculty of Medicine, Charles University, Prague, Czech Republic
  2. 2BIOCEV, Vestec, Czech Republic
  3. 3Department of Cell Biology, Faculty of Sciences, Charles University, Prague, Czech Republic
  1. Correspondence to: Jan Brábek, BIOCEV, Průmyslová 595, 25250 Vestec, Czech Republic. Tel: +42 0325873900, e-mail: jan.brabek{at}natur.cuni.cz; Karel Smetana Jr., Institute of Anatomy, 1st Faculty of Medicine, Charles University, U Nemocnice 3, 128 00 Prague 2, Czech Republic. Tel: +42 0224965873, e-mail: karel.smetana{at}lf1.cuni.cz
View Full Text

Statistics from Altmetric.com

Cited By...

  • 36 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

In Vivo
Vol. 34, Issue 5
September-October 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Raloxifene and Bazedoxifene Could Be Promising Candidates for Preventing the COVID-19 Related Cytokine Storm, ARDS and Mortality
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
5 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Raloxifene and Bazedoxifene Could Be Promising Candidates for Preventing the COVID-19 Related Cytokine Storm, ARDS and Mortality
KAREL SMETANA, DANIEL ROSEL, JAN BRÁBEK
In Vivo Sep 2020, 34 (5) 3027-3028; DOI: 10.21873/invivo.12135

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Raloxifene and Bazedoxifene Could Be Promising Candidates for Preventing the COVID-19 Related Cytokine Storm, ARDS and Mortality
KAREL SMETANA, DANIEL ROSEL, JAN BRÁBEK
In Vivo Sep 2020, 34 (5) 3027-3028; DOI: 10.21873/invivo.12135
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Footnotes
    • References
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Relevance of the viral Spike protein/cellular Estrogen Receptor-{alpha} interaction for endothelial-based coagulopathy induced by SARS-CoV-2
  • Garcinia kola and garcinoic acid suppress SARS-CoV-2 spike glycoprotein S1-induced hyper-inflammation in human PBMCs through inhibition of NF-{kappa}B activation
  • Google Scholar

More in this TOC Section

  • The Experience of Greece as a Model to Contain COVID-19 Infection Spread
  • Colorectal Cancer Surgery During the COVID-19 Pandemic: A Single Center Experience
  • Selection of the Appropriate Control Group Is Essential in Evaluating the Cytokine Storm in COVID-19
Show more Articles on Covid-19

Keywords

  • SARS-CoV-2
  • lung failure
  • cytokine storm
  • IL6
  • COVID-19 therapy
  • bazedoxifene
  • Raloxifene
In Vivo

© 2026 In Vivo

Powered by HighWire